OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to a loss of $0.29 per share a year ago.
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
OrthoPediatrics (KIDS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Wall Street Analysts Think OrthoPediatrics (KIDS) Could Surge 26.45%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade
The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC David Turkaly - Citizens JMP Securities, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to the OrthoPediatrics Corporation Third Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
OrthoPediatrics (KIDS) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.18 per share a year ago.
OrthoPediatrics Corp. (KIDS) Q3 2025 Sales Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2025 Sales Call October 9, 2025 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Hannah Jeffrey - The Gilmartin Group Ryan Zimmerman - BTIG, LLC, Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Ravi Misra - Truist Securities, Inc., Research Division Joseph Conway - Needham & Company, LLC, Research Division David Turkaly - Citizens JMP Securities, LLC, Research Division Presentation Operator Good afternoon, and welcome to the OrthoPediatrics Corporation's Third Quarter 2025 Preliminary Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants David R. Bailey - President, CEO & Director Fred L.
OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.23 per share a year ago.
OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Ryan Zimmerman - BTIG Rick Wise - Stifel Ben Haynor - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the OrthoPediatrics Corporation First Quarter 2025 Earnings Conference call.
